BOSTON SCIENTIFIC CORPORATION Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BOSTON SCIENTIFIC CORPORATION (BSX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 6.00 trillion shares for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2020-05-06
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 6.00T shares, a 100.00% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 3.00T shares.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2015-09-30 was 20.20M shares.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2015-06-30 was 17.70M shares.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2015 was 21.50M shares, a 10.42% decline from fiscal 2014.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2014 was 24.00M shares, a 26.32% increase from fiscal 2013.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2013 was 19.00M shares, a 137.50% increase from fiscal 2012.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2012 was 8.00M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-03-31 | 6.00T shares 10-Q · filed 2020-05-06 | |||||
| 2019-03-31 | 3.00T shares 10-Q · filed 2020-05-06 | |||||
| 2016-06-30 | 18.60M shares 10-Q · filed 2016-08-03 | |||||
| 2015-12-31 | 21.50M shares 10-K · filed 2018-02-20 | 22.00M shares 10-K · filed 2016-02-24 | ||||
| 2015-09-30 | 20.20M shares 10-Q · filed 2016-11-03 | 21.50M shares 10-Q · filed 2016-11-03 | ||||
| 2015-06-30 | 17.70M shares 10-Q · filed 2016-08-03 | |||||
| 2015-03-31 | 24.00M shares 10-Q · filed 2016-05-04 | |||||
| 2014-12-31 | 24.00M shares 10-K · filed 2017-02-23 | |||||
| 2013-12-31 | 19.00M shares 10-K · filed 2016-02-24 | |||||
| 2013-09-30 | 23.60M shares 10-Q · filed 2014-11-05 | 17.20M shares 10-Q · filed 2014-11-05 | ||||
| 2013-06-30 | 14.00M shares 10-Q · filed 2014-08-06 | |||||
| 2013-03-31 | 12.80M shares 10-Q · filed 2014-05-08 | |||||
| 2012-12-31 | 8.00M shares 10-K · filed 2015-02-25 | |||||
| 2012-09-30 | 6.80M shares 10-Q · filed 2013-11-05 | 62.00M shares 10-Q · filed 2012-11-06 | 7.20M shares 10-Q · filed 2013-11-05 | |||
| 2012-06-30 | 5.80M shares 10-Q · filed 2013-08-07 | 63.00M shares 10-Q · filed 2012-08-07 | 7.30M shares 10-Q · filed 2013-08-07 | |||
| 2012-03-31 | 59.00M shares 10-Q · filed 2012-05-03 | |||||
| 2011-09-30 | 65.00M shares 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | 68.00M shares 10-Q · filed 2012-08-07 | |||||
| 2011-03-31 | 55.00M shares 10-Q · filed 2012-05-03 | |||||
| 2010-12-31 | 10.00M shares 8-K · filed 2013-05-29 | |||||
| 2010-09-30 | 9.20M shares 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | 9.10M shares 10-Q · filed 2011-08-05 | |||||
| 2010-03-31 | 9.70M shares 10-Q · filed 2011-05-05 | |||||
| 2009-12-31 | 8.00M shares 10-K · filed 2012-02-17 | |||||
| 2008-12-31 | 5.80M shares 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |